Pipeline preview

November 2004
Formulary;Nov2004, Vol. 39 Issue 11, p520
Academic Journal
Updates on the U.S. Food & Drug Administration's actions on applications for drug approvals as of November 2004. Approval status of meningococcal polysaccharide diphtheria toxoid conjugate for vaccination against meningococcal disease; Drospirenone/estradiol for hormone replacement therapy; Thalidomide for the treatment of multiple myeloma.


Related Articles

  • Influence of Prior Meningococcal C Polysaccharide Vaccination on the Response and Generation of Memory after Meningococcal C Conjugate Vaccination in Young Children. Borrow, Ray; Goldblatt, David; Andrews, Nick; Richmond, Peter; Southern, Joanna; Miller, Elizabeth // Journal of Infectious Diseases;8/1/2001, Vol. 184 Issue 3, p377 

    Presents a study which determined whether the immunological hyporesponsesiveness induced by meningococcal AC polysaccharide vaccine can be overcome by meningococcal C conjugate vaccine in children. Review of related literature; Characteristics of the participants; Materials and methods used;...

  • Group A and C meningococcal vaccines.  // Weekly Epidemiological Record;9/10/99, Vol. 74 Issue 36, p297 

    Examines the efficacy of group A and C meningococcal vaccines in controlling epidemics of meningococcal meningitis. Causes of meningococcal meningitis and septicemia; Use of vaccines in large-scale immunization programs; Number of mortality associated with meningococcal diseases.

  • Meningitis B vaccine looks promising. Sheldon, Tony // BMJ: British Medical Journal (International Edition);09/19/98, Vol. 317 Issue 7161, p770 

    Reveals that Dutch researchers believe that they have found an effective vaccine to combat group B meningococcal disease. Number of cases of bacterial meningitis in the Netherlands each year; Preliminary results of clinical trials with the vaccine; What most cases of meningococcal disease in...

  • Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Greenwood, B.M.; Hassan-King, M.; Whittle, H.C. // British Medical Journal;5/20/1978, Vol. 1 Issue 6123, p1317 

    Household contacts of patients with group A meningococcal infection were vaccinated with either meningococcal vaccine or tetanus toxoid. Five of the 523 subjects who received tetanus toxoid developed meningococcal meningitis and another four probably had meningococcal disease. Only one possible...

  • Low rate of adverse reactions for MeNZB. Topham-Kindley, Liane // New Zealand Doctor;9/21/2005, p3 

    Focuses on the general practice-based intensive meningococcal vaccine monitoring programme being conducted by the New Zealand Pharmacovigilance Centre. Significant events that have occurred during the programme; Number of reactions that have been reported through the spontaneous system; Purpose...

  • In brief.  // BMJ: British Medical Journal (International Edition);8/9/2003, Vol. 327 Issue 7410, p306 

    Presents medical news briefs. Loss on appeal by two mothers who refused MMR vaccinations for their children; British Medical Association rejection of health checks for asylum seekers; Indian court support of "two children" rule for local elective candidates; Combined hormone replacement therapy...

  • A Multicenter, Open-Label Study to Evaluate Satisfaction and Menopausal Quality of Life in Women Using Transdermal Estradiol/Norethindrone Acetate Therapy for the Management of Menopausal Signs and Symptoms. Adler, George; Young, Douglas; Galant, Ron; Quinn, Laura; Witchger, Mary Sue; Maki, Kevin C. // Gynecologic & Obstetric Investigation;May2005, Vol. 59 Issue 4, p212 

    Aim: This multicenter, open-label, single-arm study evaluated subject satisfaction and improvements in menopausal quality of life among menopausal women using the CombiPatch® transdermal system consisting of 17β-estradiol 0.05 mg plus norethindrone acetate 0.14 mg in a matrix patch...

  • Vaccine for Meningococcal Meningitis Tested. Marwick, Charles // JAMA: Journal of the American Medical Association;10/16/91, Vol. 266 Issue 15, p2052 

    Reports on researchers at the U.S. National Institutes of Health's development of a vaccine that could immunize infants against meningococcal meningitis. Testing of the vaccine in mice; Lack of vaccines for meningococcal serotypes for infants; Ability of the vaccine to induce antibody to...

  • Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj. Madani, Tariq A.; Ghabrah, Tawfik M. // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p80 

    Background: The objective of this study was to assess the compliance of health care workers (HCWs) employed in Hajj in receiving the meningococcal, influenza, and hepatitis B vaccines. Methods: A cross-sectional survey of doctors and nurses working in all Mena and Arafat hospitals and primary...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics